FGF1 and type 2 diabetes mellitus: These findings collectively demonstrate that the increased activity of NPY/AgRP neurons in the Lepob/ob mouse model of T2D is reversed at least 2 weeks after i.c.v. injection of a single dose of FGF1 that reliably elicits sustained reversal of hyperglycemia in these animals (1, 2, 4).